Skip to main content
. 2018 Nov 9;321(1):69–79. doi: 10.1001/jama.2018.18269

Figure 1. Flow of Participants in the CARMELINA Trial of Linagliptin.

Figure 1.

DPP-4 indicates dipeptidyl peptidase 4; SGLT-2, sodium-glucose cotransporter 2; GLP-1, glucagon-like peptide 1.

aPatients could have more than 1 reason, so numbers sum to more than 4692.

bDefined as serum levels of alanine aminotransferase, aspartate aminotransferase, or alkaline phosphatase at least 3 times the upper limit of normal.